Lentiviral Vectors for Ocular Gene Therapy

Area of Science:

• Ophthalmology
• Gene Therapy
• Biotechnology

Background:

• Lentiviral vectors are advanced gene delivery systems with potential therapeutic applications.
• Developing safe and efficient lentiviral recombinant vectors presents global challenges for clinical use.
• Minimizing risks and side effects is crucial for the successful clinical translation of lentiviral vector technology.

Purpose of the Study:

• To review lentiviral vector technologies, their advantages, and limitations.
• To provide an overview of lentiviral vector applications in ophthalmology.
• To discuss preclinical and clinical studies on lentiviral vectors for ocular gene therapy.

Main Methods:

• Review of existing literature on lentiviral vector technology.
• Analysis of global challenges in developing safe and efficient lentiviral vectors.
• Examination of preclinical and clinical studies focusing on ocular gene therapy.

Main Results:

• Lentiviral vectors present a viable alternative for gene therapy across all ocular compartments.
• Gene therapy using lentiviral vectors is under development for numerous ocular conditions.
• Safety and efficacy data from preclinical and clinical studies support their use in treating eye diseases.

Conclusions:

• Lentiviral vectors are a significant tool for advancing gene therapy in ophthalmology.
• Ongoing research addresses challenges to optimize lentiviral vector safety and efficacy for ocular applications.
• The potential of lentiviral vectors spans a wide range of debilitating eye conditions, offering new therapeutic avenues.